Tag: medical marijuana

Congress Abandons Effort To Let VA Doctors Recommend Medical Marijuana On Veterans Day

Advocates are sharply criticizing congressional leaders for advancing a spending bill ahead of Veterans Day on Tuesday that omits bipartisan provisions allowing U.S. Department of Veterans Affairs (VA) doctors to recommend medical cannabis to patients in states where it’s legal—even though the policy was approved by the full Senate and House of Representatives earlier this year.

While there’s been significant focus on language in appropriations legislation that passed the Senate on Monday that would ban hemp products containing THC, another key setback for reform advocates is the lack of the medical marijuana provisions for veterans—different versions of which advanced through both chambers.

“The absence of this provision is incredibly disappointing, and makes no sense whatsoever,” Morgan Fox, political director of NORML, told Marijuana Moment. “It is uncontroversial, revenue-neutral, previously approved by both chambers, and long overdue in order to help veterans find relief.”

“The timing of the announcement—just days before a holiday to show our gratitude to service members—is quite insensitive,” he said, referring to the bill’s unveiling on Sunday, just two days before Veterans Day.

Here’s the text of the House-passed version: 

“None of the funds appropriated or otherwise made available to the Department of Veterans Affairs in this Act may be used to enforce Veterans Health Directive 1315 as it relates to—

(1) the policy stating that ‘VHA providers are prohibited from completing forms or registering Veterans for participation in a State-approved marijuana program’;

(2) the directive for the ‘Deputy Under Secretary for Health for Operations and Management’ to ensure that ‘medical facility Directors are aware that it is VHA policy for providers to assess Veteran use of marijuana but providers are prohibited from recommending, making referrals to or completing paperwork for Veteran participation in State marijuana programs’; and

(3) the directive for the ‘VA Medical Facility Director’ to ensure that ‘VA facility staff are aware of the following’ ‘[t]he prohibition recommending, making referrals to or completing forms and registering Veterans for participation in State-approved marijuana programs’.”

The Senate-passed language reads:

“None of the funds appropriated or otherwise made available to the Department of Veterans Affairs in this Act may be used in a manner that would—

(1) interfere with the ability of a veteran to participate in a medicinal marijuana program approved by a State;

(2) deny any services from the Department to a veteran who is participating in such a program; or

(3) limit or interfere with the ability of a health care provider of the Department to make appropriate recommendations, fill out forms, or take steps to comply with such a program.”

The negotiated bill contains no language on the issue at all.

“Denying our veterans access to a medicine that so many use to ease physical pain, or the trauma of PTSD, is straight cruelty,” Adam Smith, executive director of the Marijuana Policy Project (MPP), told Marijuana Moment.

Keep reading

Congressional Deal Would Ban Many Hemp THC Products, While Excluding Provisions To Let VA Doctors Recommend Medical Marijuana

Newly released spending legislation negotiated by congressional leaders would federally recriminalize many hemp-derived products. It also excludes provisions previously passed by the House and Senate that would have allowed Department of Veterans Affairs (VA) doctors to begin issuing medical marijuana recommendations to their patients.

The new measure, if enacted into law, would ban certain hemp products that were legalized under the 2018 Farm Bill signed into law by President Donald Trump during his first term.

The negotiated bill “prevents the unregulated sale of intoxicating hemp-based or hemp-derived products, including Delta-8, from being sold online, in gas stations, and corner stores, while preserving non-intoxicating CBD and industrial hemp products,” a summary published on Sunday by the Senate Appropriations Committee says.

Under current law, cannabis products are considered legal hemp if they contain less than 0.3 percent delta-9 THC on a dry weight basis.

The new legislation specifies that, within one year of enactment, the weight would apply to total THC—including delta-8 and other isomers. It would also include “any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).”

The new definition of legal hemp would additionally ban “any intermediate hemp-derived cannabinoid products which are marketed or sold as a final product or directly to an end consumer for personal or household use” as well as products containing cannabinoids that are synthesized or manufactured outside of the cannabis plant or not capable of being naturally produced by it.

Legal hemp products would be limited to a total of .4 milligrams of total THC or any other cannabinoids with similar effects.

Within 90 days of the bill’s enactment, the Food and Drug Administration (FDA) and other agencies would need to publish list of “all cannabinoids known to FDA to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature,” “all tetrahydrocannabinol class cannabinoids known to the agency to be naturally occurring in the plant” and “all other know cannabinoids with similar effects to, or marketed to have similar effects to, tetrahyrocannabinol class cannabinoids.”

The deal was agreed to by Senate Appropriations Committee Chair Susan Collins (R-ME) and Sen. Patty Murray (D-WA), the ranking minority member on the panel, as well as House Appropriations Committee Chair Tom Cole (R-OK). But Rep. Rosa DeLauro (D-CT), the top Democrat on the House panel, did not sign off.

The language slightly differs from provisions included in legislation that had previously advanced out of the House and Senate Appropriations panels, which would have banned products containing any “quantifiable” amount of THC, to be determined by the HHS secretary and secretary of agriculture.

Separately, the newly released appropriations legislation excludes language that had been passed by either chamber earlier this year to let VA doctors recommend medical cannabis to their military veteran patients in states where it is legal.

Keep reading

Florida Officials Are Revoking Medical Marijuana IDs From Patients And Caregivers With Drug Convictions Under Law Signed By DeSantis

Florida medical marijuana officials are actively revoking the registrations of patients and caregivers with drug-related criminal records.

The policy is part of broad budget legislation signed into law earlier this year by Gov. Ron DeSantis (R). The provisions in question direct the state Department of Health (DOH) to cancel registrations of medical marijuana patients and caregivers if they’re convicted of—or plead guilty or no contest to—criminal drug charges.

The measure says a patient or caregiver will have their registration immediately suspended upon being charged with a covered state drug crime, and the suspension will remain in place until the criminal case reaches a final disposition. DOH officials have authority to reinstate the registration, revoke it entirely or extend the suspension if needed.

Bobbie Smith, director of the Florida Office of Medical Marijuana Use (OMMU), told lawmakers on Wednesday that regulators are already banning people from the medical cannabis program under the new policy.

OMMU has “identified 20 individuals that meet the new requirement for revocation, and there’s roughly 140 that we’re still monitoring as they wait make their way through the criminal justice system,” she said at a hearing of the House Health Professions & Programs Subcommittee in comments first reported by Florida Politics.

Under the law, authorities are required to revoke a person’s registration if the patient or caregiver “was convicted of, or pled guilty or nolo contendre to, regardless of adjudication, a violation [of state drug law] if such violation was for trafficking in, the sale, manufacture, or delivery of, or possession with intent to sell, manufacture, or deliver a controlled substance.”

The enacted version of the legislation focuses specifically on production and distribution. It does not contain an earlier restriction from prior versions that would have also revoked registrations for people who merely purchased illegal drugs, including more than 10 grams of marijuana for their own use.

It also clarifies that patients and caregivers have a process to request their registrations be reinstated. That involves submitting a new application “accompanied by a notarized attestation by the applicant that he or she has completed all the terms of incarceration, probation, community control, or supervision related to the offense.”

It’s not clear from the plain language of the revised bill whether it will impact only future criminal cases involving medical marijuana patients and caregivers or whether DOH would need to review the records of existing program registrants and revoke registrations of an untold number of Floridians with past drug convictions.

Keep reading

Legalizing Medical Marijuana Leads To ‘Significant Reductions’ In Opioid Prescriptions, Another Study Shows

Medical marijuana legalization is “associated with significant reductions in opioid prescribing,” yet another new study has found.

Researchers at the University of Georgia and University of Colorado analyzed prescription claims for 15 to 20 million insured Americans annually from 2007-2020, comparing the prevalence of opioid prescriptions in states with and without medical cannabis programs in place.

“We find that [medical cannabis laws, or MCLs] are associated with significant reductions in opioid prescribing,” the study, published in the American Journal of Health Economics, found. “Among treated states, the rate of patients receiving opioid prescriptions fell by 16% on average, masking substantial heterogeneity across states, with individual state declines reaching 22%.”

“We also find significant decreases in the intensive margin, both in the daily supply and prescriptions per patient,” the researchers said. “Among subpopulations, decreases were relatively uniform across sex, age, and race/ethnicity, though cancer patients, and non-cancer Black patients experienced a larger reduction (over 20%).”

The study also identified increases in the frequency of use of NSAID pain medications, “suggesting that MCLs are associated with substitution away from opioids toward safer alternatives.”

Keep reading

Newsom Vetoes California Bill To Let Marijuana Businesses Deliver Products Directly To Patients

The governor of California has vetoed a bill that would have allowed certain marijuana microbusinesses to ship medical cannabis products directly to patients via common carriers like FedEx and UPS, stating that the proposal “would be burdensome and overly complex to administer.”

After advancing through the legislature last month, the measure from Assemblymember Patrick Ahrens (D) was rejected by Gov. Gavin Newsom (D) on Saturday.

“This bill would authorize a limited number of cannabis microbusinesses to ship certain medicinal cannabis products directly to patients using a common carrier,” the governor said in a veto message.

An analysis of the legislation says supporters argue that “a small population of patients in California requires specific medicinal products that retailers do not stock, as only a handful of individuals seek them, and these products are perishable.”

“This bill is intended to create flexibility for medical patients and caregivers for whom it is a hardship to travel to purchase medicinal cannabis products. However, prior amendments narrowed the scope of the bill by prohibiting the shipment of medicinal cannabis goods to patients who live within 60 miles of a cannabis retailer or delivery option. It is unclear how many patients currently stand to benefit from this bill.”

The bill sponsor, Ahrens, said in the analysis that “the availability of medical cannabis products has declined significantly due to regulatory burdens, high taxation, and the prioritization of adult-use recreational products over medicinal formulations.”

“As a result, many patients—particularly those with intractable epilepsy, advanced cancers, multiple sclerosis, and neurodegenerative disorders—are struggling to obtain appropriate and effective medical cannabis products,” he said. “California’s vast geography further exacerbates this issue, as many seriously ill patients live in areas where specialized medical cannabis products are not available locally and these patients are not able to travel long distances to dispensaries that carry the products they need.”

Keep reading

Spain legalises medical cannabis in ‘historic’ move

Spain‘s government has today legalised medical cannabis in what has been described as a ‘historic’ move. 

The country’s Council of Ministers today approved cannabis to be prescribed to patients as an ailment to their illnesses. 

But prescriptions can only be handed out under strict conditions. 

Only specialists in hospitals may prescribe cannabis to patients. 

But the government has not set out what ailments the drug should be prescribed for, instead saying that a specialised government agency will set out the rules in the coming weeks. 

Carola Pérez, president of the Spanish Observatory of Medicinal Cannabis, described the decision as ‘historic’. 

She added: ‘All of us patients who were waiting for regulation are celebrating’.

She added that the move opens the door for cannabis to be prescribed for a wide range of illnesses. 

Studies have shown that it can help ease the pain of multiple sclerosis and certain forms epilepsy, and can limit nausea and vomiting associated with chemotherapy. 

But she added that she wants to make sure Spanish doctors correctly prescribe cannabis, especially in light of the high demand: ‘We’re afraid that doctors won’t know exactly when to prescribe it, because they’re generally untrained. 

‘And we’re also afraid that there will be a bottleneck in hospital laboratories due to the high demand for these compounds’.

Keep reading

Terminally Ill Patients Would Be Able To Use Medical Marijuana In Pennsylvania Hospitals Under New Bipartisan Bill

Bipartisan Pennsylvania senators have introduced a bill that would allow terminally ill patients to use of medical marijuana in hospitals.

Similar to a law previously enacted in California, the Pennsylvania legislation from Sen. John Kane (D) and 17 bipartisan cosponsors aims to ensure that cannabis patients with severe illnesses such as cancer retain access to regulated products as an alternative treatment option.

“Hospitals are incredible places where patients receive top notch care,” Kane wrote in a cosponsorship memo in August. “They need guidance and legal protections to provide terminally ill patients with options to manage pain, while providing settings that support family and friends who are saying goodbye to a loved one.”

The policy that’s being proposed in the bill filed on Friday is known as “Ryan’s law,” a reference to Ryan Bartell, a cancer patient who inspired the legislation.

“During his treatments in California the hospital provided him with opioid medications that caused him to be sedated and unable to interact with family and friends,” Kane said. “Ryan and his family wanted to ensure that his remaining days could be filled with visits from his loved ones. So, Ryan moved to a hospital in the State of Washington where he used medical marijuana to manage his pain effectively and allow him to stay awake and alert to spend time with family and friends during hospital visits.”

“Ryan’s law would allow terminally ill patients to use non-smoking forms of medical marijuana in Pennsylvania hospitals,” he said. “Right now, the use of medical marijuana in hospitals is a gray area due to marijuana being a Scheduled I Narcotic, while also being legal for medicinal purposes in Pennsylvania.”

The four-page bill would amend the state’s existing medical cannabis law to make it so terminally ill patients can use non-smokeable marijuana products at hospitals, create storage requirements for the medicine and require health facilities to develop guidelines about the regulated use of cannabis for qualifying patients.

It also stipulates that a “health care facility is not required to provide a patient with a recommendation to use medical marijuana in compliance with this act or include medical marijuana in a patient’s discharge plan.”

Additionally, the measure says that, if the federal government initiates enforcement actions against a hospital regarding the cannabis policy or issues rules expressly prohibiting the medical marijuana allowance, the health facility is empowered to suspend the practice.

However, the proposed law “shall not be construed to permit a health care facility to prohibit patient use of medical marijuana due solely to the fact that cannabis is a Schedule I drug under the Controlled Substances Act or other Federal constraints on the use of medical marijuana that were in existence prior to the effective date of this paragraph,” it says.

Keep reading

Nebraska Officials Miss Medical Marijuana Licensing Deadline As Regulators Resign

Supporters have questioned for months whether the voter-authorized Nebraska Medical Cannabis Commission would meet its October 1 deadline to grant its first licenses.

The answer is no: The commission will miss that deadline by at least one week, in the wake of two resignations sought and received by Gov. Jim Pillen (R) of liquor regulators who jointly served on the medical cannabis board.

The Medical Cannabis Commission confirmed the new timeline Tuesday at a meeting originally meant to approve the first cultivator licenses and move toward the first steps of a medical cannabis supply chain in the state. However, two of the five cannabis commissioners resigned Monday, both of whom served on a three-member team evaluating and scoring cultivator applications received by September 23.

Now, the remaining commissioners will independently review applications by next Tuesday, when commissioners will meet to decide whether to award up to four cultivator licenses.

“We would just ask for your understanding that this is a situation that none of us created in this, where we’re at right here,” Commissioner Lorelle Mueting of Gretna said Tuesday. “We would just hope you understand that we’re working through this the best that we can to make sure that we get the licenses issued in a timely manner and evaluated and issued in time.”

Keep reading

Feds Call Marijuana A ‘Deadly’ Drug And Say Even Medical Cannabis Has ‘Serious Consequences’

Federal officials are calling marijuana a “deadly” drug—touting their efforts to seize it and other illegal substances—while also warning that possessing cannabis, even for medical use, carries “serious consequences.”

As President Donald Trump considers a cannabis rescheduling proposal—and after he posted a video on the health benefits of CBD—the Department of Homeland Security (DHS) and Customs and Border Protection (CBP) are sending a conflicting message about cannabis.

In a press release about an August “surge” in drug seizures that was sent out on Tuesday, DHS said that CBP, as part of its “mission to stop harmful drugs from entering the United States,” was announcing that “seizures of deadly drugs—including fentanyl, cocaine, heroin, methamphetamine, and marijuana—increased substantially from July to August.”

That rhetoric as it concerns marijuana departs from how most people view and compare the plant with the other listed substances that can be associated with overdose deaths. By the federal government’s own admission in the past, cannabis has not on its own caused a fatal overdose.

“Cartels are increasingly desperate to keep doing business, but the Trump Administration is stopping their deadly operations,” CBP said.

While looping together marijuana and drugs like fentanyl might raise eyebrows, cartel-related crime associated with cannabis has been a consistent talking point in Congress. In fact, it was the subject of a House Homeland Security Subcommittee on Oversight, Investigations, & Accountability hearing last month that focused on a so-called “invasion” of Chinese and Mexican cartels via illicit cannabis operations.

“Secretary Noem and the Department of Homeland Security are fulfilling President Trump’s promise to make America safe again by dismantling drug cartels and stopping the flow of deadly drugs into American communities,” DHS Assistant Secretary Tricia McLaughlin said. “Thanks to President Trump, fewer American families will be torn apart by addiction, fewer lives will be lost to overdoses, and fewer profits will go to violent cartels.”

Separately, CBP posted a reminder on social media on Tuesday that cautioned travelers against bringing cannabis across the border.

“Attention, travelers! Did you know that marijuana is still a controlled substance under U.S. federal law?” it said. “This means that selling, possessing, producing, or distributing both medical and recreational cannabis is illegal!”

Keep reading

Oklahoma Medical Marijuana Patient Count Falls to Lowest Level Since June 2020

The new figure marks the eighth consecutive month of decline, down from 326,828 in July and well below the 2022 peak of nearly 387,000 patients.

The downward trend comes as Oklahoma’s once rapidly expanding program stabilizes and tightens. When voters approved medical marijuana in 2018, the program quickly became one of the most accessible in the nation, with low barriers to entry and no cap on business licenses. At its height, nearly 10% of the state’s population held medical marijuana cards, a rate unmatched anywhere else in the country.

Since then, the state has also introduced more stringent oversight, which may be contributing to the shrinking patient base. Several readers have contacted out to us in recent weeks to say that their renewal was denied, but they were given no reason as to why. We reached out to the Oklahoma Medical Marijuana Authority for comment, but they have yet to provide a response.

Another factor contributing to the decrease in medical cannabis patients is the proliferation of hemp-derived THC products, which can be found easily in smoke shops and online.

In the meantime, advocates with Oklahomans for Responsible Cannabis Action are working to place a recreational marijuana measure on the November 2026 ballot. The proposal would allow adults 21 and older to possess, purchase, and grow marijuana while creating a taxed retail system. Petitions are now available at more than 400 sites in over 100 cities, giving supporters widespread access as the campaign pushes forward.

Keep reading